Brent Rosenthal, DPM
Foot & Ankle Surgery · Freehold, NJNPI 1053495887
Payments from drug & device makers
What this record shows
This record is dominated by gifts: $43,400 of the $43,901 with a category attached, or 98.9%. Smith+Nephew accounts for 98.9% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $43,646 and has fallen 99.8% since, to $75 in 2025. Among foot & ankle surgery clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 11 payments — averaging $3990.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$43K
- Aroa Biosurgery Incorporated$173
- Kerecis Limited$143
- Organogenesis Inc.$64
- Stryker$39
- Novartis$35
- plus $15 from 1 others
What the payments were for
- Travel & lodging$190%
- Food & beverage$4821%
- Gifts$43,40099%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 2 | $43,432 |
| Aroa Biosurgery Incorporated | 1 | $173 |
| Kerecis Limited | 2 | $143 |
| Organogenesis Inc. | 3 | $64 |
| Stryker | 1 | $39 |
| Novartis | 1 | $35 |
| Merck | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Stravix$43,400
- Grafix$43,400
- GrafixPL$43,400
- Kerecis Omega3 Marigen$306
- Kerecis Omega3 SurgiClose$102
- Kerecis Omega3 GraftGuide$102
How this compares
$43,901 in reported general payments places this provider in the 95th percentile of 542 foot & ankle surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Colchicine | 17 | $888 |
| Ammonium Lactate | 16 | $457 |
| Terbinafine Hcl | 12 | $169 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 22 | $110 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Freehold
- John CozzarelliBelleville$932K
- Matthew RegulskiToms River$843K
- Michael SubikLyndhurst$529K
- Krupa PatelMorris Plains$281K
- Johanna GodoyWayne$254K
- Andrew BriefRidgewood$253K
- Mark SolomonCedar Knolls$232K
- Evan AdlerOld Bridge$195K
- Shane HollawellManasquan$169K
- Jacob ReinkrautRidgewood$80K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.